By Melissa Lipman ( June 18, 2013, 9:40 PM EDT) -- When the U.S. Supreme Court ruled Monday that pay-for-delay deals may violate antitrust law, it largely left it up to the lower courts to figure out how to make the traditional rule-of-reason analysis work for the pharmaceutical patent settlements....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.